Strict glucose control and artificial regulation of the NO-ADMA-DDAH system in order to prevent endothelial dysfunction.
作者信息
Brinkmann Saskia J H, Wörner E A, van Leeuwen Paul A M
机构信息
Department of Surgery, VU University Medical Center, Amsterdam, The Netherlands.
出版信息
J Physiol. 2016 Jun 1;594(11):2775-6. doi: 10.1113/JP272183.
Abstract
摘要
相似文献
1
Strict glucose control and artificial regulation of the NO-ADMA-DDAH system in order to prevent endothelial dysfunction.
J Physiol. 2016 Jun 1;594(11):2775-6. doi: 10.1113/JP272183.
2
Involvement of DDAH/ADMA/NOS pathway in nicotine-induced endothelial dysfunction.
Biochem Biophys Res Commun. 2006 Oct 20;349(2):683-93. doi: 10.1016/j.bbrc.2006.08.115. Epub 2006 Aug 28.
3
Nitric oxide upregulates dimethylarginine dimethylaminohydrolase-2 via cyclic GMP induction in endothelial cells.
Hypertension. 2008 Nov;52(5):903-9. doi: 10.1161/HYPERTENSIONAHA.108.114207. Epub 2008 Sep 29.
4
Vascular endothelium is the organ chiefly responsible for the catabolism of plasma asymmetric dimethylarginine--an explanation for the elevation of plasma ADMA in disorders characterized by endothelial dysfunction.
Med Hypotheses. 2004;63(4):699-708. doi: 10.1016/j.mehy.2002.11.008.
5
The ADMA/DDAH/NO pathway in human vein endothelial cells exposed to arsenite.
Toxicol In Vitro. 2017 Aug;42:281-286. doi: 10.1016/j.tiv.2017.05.008. Epub 2017 May 11.
6
Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine.
Eur J Pharmacol. 2008 Apr 14;584(1):49-56. doi: 10.1016/j.ejphar.2008.01.029. Epub 2008 Feb 5.
7
Human recombinant erythropoietin augments serum asymmetric dimethylarginine concentrations but does not compromise nitric oxide generation in mice.
Nephrol Dial Transplant. 2008 May;23(5):1513-20. doi: 10.1093/ndt/gfm869. Epub 2008 Jan 19.
8
Pyrrolidine dithiocarbamate ameliorates endothelial dysfunction in thoracic aorta of diabetic rats by preserving vascular DDAH activity.
PLoS One. 2017 Jul 17;12(7):e0179908. doi: 10.1371/journal.pone.0179908. eCollection 2017.
9
Inhibitory effect of resveratrol derivative BTM-0512 on high glucose-induced cell senescence involves dimethylaminohydrolase/asymmetric dimethylarginine pathway.
Clin Exp Pharmacol Physiol. 2010 May;37(5-6):630-5. doi: 10.1111/j.1440-1681.2010.05368.x. Epub 2010 Feb 4.
10
Taurine protects against low-density lipoprotein-induced endothelial dysfunction by the DDAH/ADMA pathway.
Vascul Pharmacol. 2007 May;46(5):338-45. doi: 10.1016/j.vph.2006.11.006. Epub 2007 Jan 19.
引用本文的文献
1
Asymmetric dimethylarginine (ADMA) accelerates renal cell fibrosis under high glucose condition through NOX4/ROS/ERK signaling pathway.
Sci Rep. 2020 Sep 29;10(1):16005. doi: 10.1038/s41598-020-72943-2.
本文引用的文献
1
Asymmetric dimethylarginine (ADMA) elevation and arginase up-regulation contribute to endothelial dysfunction related to insulin resistance in rats and morbidly obese humans.
J Physiol. 2016 Jun 1;594(11):3045-60. doi: 10.1113/JP271836. Epub 2016 Mar 4.
2
Modulating DDAH/NOS Pathway to Discover Vasoprotective Insulin Sensitizers.
J Diabetes Res. 2016;2016:1982096. doi: 10.1155/2016/1982096. Epub 2015 Dec 6.
3
The Arginine/ADMA Ratio Is Related to the Prevention of Atherosclerotic Plaques in Hypercholesterolemic Rabbits When Giving a Combined Therapy with Atorvastatine and Arginine.
Int J Mol Sci. 2015 May 29;16(6):12230-42. doi: 10.3390/ijms160612230.
4
Asymmetric dimethylarginine and critical illness.
Curr Opin Clin Nutr Metab Care. 2014 Jan;17(1):90-7. doi: 10.1097/MCO.0000000000000020.
5
Preserved endothelial function in human obesity in the absence of insulin resistance.
J Transl Med. 2013 Oct 20;11:263. doi: 10.1186/1479-5876-11-263.
6
Ceramide mediates vascular dysfunction in diet-induced obesity by PP2A-mediated dephosphorylation of the eNOS-Akt complex.
Diabetes. 2012 Jul;61(7):1848-59. doi: 10.2337/db11-1399. Epub 2012 May 14.
7
Vascular insulin resistance in prehypertensive rats: role of PI3-kinase/Akt/eNOS signaling.
Eur J Pharmacol. 2010 Feb 25;628(1-3):140-7. doi: 10.1016/j.ejphar.2009.11.038. Epub 2009 Nov 27.
8
The clinical significance of asymmetric dimethylarginine.
Annu Rev Nutr. 2006;26:203-28. doi: 10.1146/annurev.nutr.26.061505.111320.
9
Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: a possible explanation of reduced morbidity and mortality?
Crit Care Med. 2005 Mar;33(3):504-10. doi: 10.1097/01.ccm.0000155784.59297.50.
10
Impairment of PI3-K/Akt pathway underlies attenuated endothelial function in aorta of type 2 diabetic mouse model.
Hypertension. 2004 Dec;44(6):956-62. doi: 10.1161/01.HYP.0000147559.10261.a7. Epub 2004 Oct 25.
Zotero 插件